Company and History
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company was founded in 2002 based on world-leading research at the University of Oxford. The European headquarters are located in Abingdon, UK and the North American headquarters are located in Marlborough, MA USA.
T-SPOT® technology is an innovative platform technology for diagnosing disease. The technology is a simple and accurate method of measuring a person’s immune response to infection.
The company’s first product is the T-SPOT®.TB test, the new cellular blood test for the detection of active and latent TB infection. The test was CE marked in Europe in July 2004, licensed in Canada in 2005 and was FDA approved in the United States in July of 2008.